GSEA showed many pathways were similarly enriched across mdTAM_2/3, mdTAM_4 and rTAM in anti-PD-L1-treated tumours, including ‘TNFα signaling via NFκB’ and ‘Inflammatory response’ (Supplementary Fig S8B). The gene discussed is NFKB1; the disease is neoplasm.